Study | Sample size | Follow-up duration | Readmission rate (%) | Specific readmission predictors identified |
Khera et al 10 | 39 305 | 30 days | 16.2 | Anaemia. Acute kidney injury. Chronic kidney disease. Chronic lung disease. Chronic liver disease. Atrial fibrillation. Discharge disposition. Index admission ≥5 days. |
Ando et al 43 | 46 794 | 30 days | 14.5 | n/a |
Sanchez et al 20 | 10 345 | 30 days | 9.2 | Diabetes. Chronic kidney disease (Cr >1.6). Atrial fibrillation. Index admission ≥5 days. Vascular complication. Advanced heart failure. Home oxygen. Decreased 5 m gait speed. ≥Moderate aortic or mitral regurgitation. |
Danielsen et al 12 | Meta-analysis of 20 studies | 30 days | 16 | Non-transfemoral TAVR. >1 admission in year pre-TAVR. Diabetes. Chronic kidney disease. Chronic lung disease. Atrial fibrillation. Major bleeding. Index admission >7 days. |
Kolte et al 16 | 12 221 | 30 days | 17.9 (61.8 non-cardiac) | Transapical TAVR. Acute kidney injury. Chronic kidney disease. Chronic lung disease. Elixhauser comorbidities. Discharge to nursing facility. Index admission >5 days. |
Vejpongsa et al 15 | 4902 | 30 days | 17.2 (65.2 non-cardiac) | Female sex. Transapical TAVR. Congestive heart failure. Chronic obstructive pulmonary disease. Non-teaching hospital. |
Arai et al 4 | 1215 | 30 days | 3.5 | Acute kidney injury. |
1 year | 18.4 (65.5 non-cardiac) | Anaemia. Hypoalbuminaemia. Atrial fibrillation. ≥Moderate aortic regurgitation. | ||
Nombela-Franco et al 17 | 720 | 30 days | 14.6 | Anaemia. Low LVEF. Antiplatelet+anticoagulation therapy at discharge. Major bleeding. |
1 year | 43.9 (59 non-cardiac) | Chronic kidney disease. Chronic obstructive pulmonary disease. Peripheral vascular disease. Atrial fibrillation. | ||
Holmes et al 2 | 12 182 | 30 days | 17.4 | n/a |
1 year | 53.2 | Female sex. Non-transfemoral TAVR. Moderate or severe lung disease. Renal failure. Low LVEF. Increased STS PROM score. | ||
Franzone et al 23 | 868 | 1 year | 25.4 (53.9 non-cardiac) | Male sex. Chronic kidney disease. Previous myocardial infarction. Atrial fibrillation. Major bleeding. |
Cr, creatinine (mg/dL); LVEF, left ventricular ejection fraction; STS PROM, Society of Thoracic Surgeons Predicted Risk of Mortality; TAVR, transcatheter aortic valve replacement.